Common Therapy for Prostate Cancer May Promote Metastasis

A study published in the journal Cancer Research last month suggests that the principle treatment for advanced prostate cancer may actually encourage prostate cancer cells to metastasize [1]. Researchers at The Johns Hopkins University School of Medicine focused on a gene called Nestin, which encodes an intermediate filament protein. Intermediate filaments are cytoskeletal or scaffolding structures found in cells that, in addition to maintaining cell shape, control a variety of cellular processes including proliferation, migration and survival [2]. Nestin gene expression also distinguishes stem cells from differentiated cells and has been shown to be activated in pediatric brain tumors and rhabdomyosarcomas (cancers that develop from skeletal muscle), central nervous system tumors and gastrointestinal stromal tumors [3-6].

Quercetin

Quercetin is a polyphenol, one of a number of water-soluble plant pigments called flavonoids (meaning class of plant secondary metabolites known for their antioxidant activity) that are largely responsible for the color of many flowers, fruits and vegetables. High concentrations of quercetin are found in apples, onions, tea and red wine [1]. Other sources of quercetin include olive oil, grapes, broccoli, cauliflower, cabbage, dark cherries and dark berries such as blueberries, blackberries and bilberries. The average U.S. citizen eating a normal, healthy diet including fruits and vegetables consumes approximately 25-50 mg of quercetin/day. Quercetin and other flavonoids (also referred to as bioflavonoids) cannot be produced in the human body.

Decrease in US Cancer Deaths

In 2003, cancer deaths in the United States decreased by 369 deaths compared to 2002, the first drop seen since 1930. In 2004, the decrease in cancer deaths was eight times greater – 3,014 deaths – than in 2003, according to a report published in the latest issue of the American Cancer Society (ACS) journal CA: A Cancer Journal for Clinicians [1].

Experts are attributing the decreases to declines in smoking, earlier detection and more effective treatment of tumors. The three most common cancers — breast cancer, prostate cancer and colorectal cancer – show a decrease in death rates, with the largest change from colorectal cancer. Experts attribute much of the credit for the reduction in colorectal cancer to screening exams and the early detection of polyps that can be removed before they become cancerous.